New Drug ApprovalAstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE AstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE Read Post »
Clinical TrialsZydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Zydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Read Post »
New Drug ApprovalCHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... CHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... Read Post »
Disease & DrugsJohnson & Johnson to Acquire Atraverse Medical, Expanding Cardiac Ablat... Johnson & Johnson to Acquire Atraverse Medical, Expanding Cardiac Ablat... Read Post »
Clinical TrialsKyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Kyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Read Post »
New Drug ApprovalRegeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Regeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Read Post »
Clinical TrialsCatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial CatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial Read Post »
Clinical TrialsNeurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Neurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Read Post »
Clinical TrialsNovo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Novo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Read Post »
Clinical TrialsCapricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Capricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Read Post »
Clinical TrialsKyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Kyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Read Post »
New Drug ApprovalDupixent Breaks New Ground in Pediatric Chronic Urticaria Care Dupixent Breaks New Ground in Pediatric Chronic Urticaria Care Read Post »
New Drug ApprovalTzield pushes back the clock on T1D in young children with FDA nod Tzield pushes back the clock on T1D in young children with FDA nod Read Post »
Clinical TrialsNeurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Neurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Read Post »
Clinical TrialsJohnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Johnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Read Post »
New Drug ApprovalIpsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Ipsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Read Post »
Clinical TrialsRoche Advances a New Front in MS Treatment Roche Advances a New Front in MS Treatment Read Post »
Clinical TrialsENSPRYNG Signals a Breakthrough for Roche in MOGAD ENSPRYNG Signals a Breakthrough for Roche in MOGAD Read Post »
New Drug ApprovalMerck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Merck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Read Post »
Clinical TrialsAfter the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path After the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path Read Post »
Clinical TrialsMerck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Merck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Read Post »
Clinical TrialsAstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... AstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... Read Post »
New Drug ApprovalEU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... EU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... Read Post »
New Drug ApprovalBlenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Blenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Read Post »
Clinical TrialsBicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Bicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Read Post »
Clinical TrialsLundbeck Highlights Brain Fog Improvements with Eptinezumab Lundbeck Highlights Brain Fog Improvements with Eptinezumab Read Post »
Clinical TrialsAstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD AstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD Read Post »
Clinical TrialsNew data from United Therapeutics points to earlier action in pulmonary hyp... New data from United Therapeutics points to earlier action in pulmonary hyp... Read Post »
Clinical TrialsXenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Xenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Read Post »
Clinical TrialsNovo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Novo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Read Post »
ResearchZai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Zai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Read Post »
ResearchWhat Is the Optimal Time to Take Statins: Morning or Evening? What Is the Optimal Time to Take Statins: Morning or Evening? Read Post »
Clinical TrialsSanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Sanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Read Post »
Clinical TrialsModerna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Moderna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Read Post »
New Drug ApprovalShifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Shifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Read Post »
Clinical TrialsZai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Zai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Read Post »
Clinical TrialsNuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Nuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Read Post »
Clinical TrialsGigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... GigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... Read Post »
Clinical TrialsRoche advances Elevidys with planned Phase III study to support EMA resubmi... Roche advances Elevidys with planned Phase III study to support EMA resubmi... Read Post »
New Drug ApprovalEC Approves ENFLONSIA for RSV Prevention in Infants Across Europe EC Approves ENFLONSIA for RSV Prevention in Infants Across Europe Read Post »
New Drug ApprovalNICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS NICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS Read Post »
Clinical TrialsLilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Lilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Read Post »
Clinical TrialsTurning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Turning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Read Post »
Clinical TrialsBayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Bayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Read Post »
Clinical TrialsAicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Aicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Read Post »
New Drug ApprovalFDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment FDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment Read Post »
Drugs Safety AlertFDA Requires Extensive Postmarketing Safety Data for Foundayo FDA Requires Extensive Postmarketing Safety Data for Foundayo Read Post »
Clinical TrialsAstellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Astellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Read Post »
Clinical TrialsINGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence INGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence Read Post »
Clinical TrialsAligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Aligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Read Post »
